Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024
MONTREAL, Dec. 13, 2023 /PRNewswire/ – Cannara Biotech Inc. (“Cannara” or the “Company“) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it will host the Company’s annual general meeting of shareholders on January 25th, 2024 at 11:00 am EST. The meeting will be held by way of a live webcast and teleconference (per the instructions below).
Related news for (LOVFF)
- Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
- Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025
- Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
- Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025
- Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025